![Arthur Levin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arthur Levin
Directeur/Bestuurslid bij
STOKE THERAPEUTICS, INC.
Vermogen: 726 908 $ op 30-06-2026
Profiel
Arthur A. Levin currently serves as Independent Director at Stoke Therapeutics, Inc. since 2015 and as a Member of the Supervisory Board at Amylon Therapeutics BV.
Former positions include Director & Strategic Leader at Avidity Biosciences, Inc. from 2023 to 2026, Director at Oligonucleotide Therapeutics Society, Inc., Senior Vice President-Development at Ionis Pharmaceuticals, Inc., Executive Vice President-Research & Development at miRagen Therapeutics, Inc. from 2012 to 2014, Research Leader at Hoffmann-La Roche, Inc., and Chief Development Officer & Vice President at RICC A. Education includes a doctorate from Rochester Christian University and an undergraduate degree from Muhlenberg College, conferred in 1975.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 03-06-2026 | 22.216 ( 0,04% ) | 726 908 $ | 30-06-2026 |
Actieve functies van Arthur Levin
| Bedrijven | Functie | Begin |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-09-2015 |
Amylon Therapeutics BV
 Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Develops therapies for central nervous system | Directeur/Bestuurslid | - |
Eerdere bekende functies van Arthur Levin
| Bedrijven | Functie | Einde |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | 23-02-2023 |
miRagen Therapeutics, Inc. /Old/
 miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops microRNA-based therapeutics for cardiovascular and muscle diseases | Hoofd Techniek/Wetenschap/O&O | 01-01-2014 |
Oligonucleotide Therapeutics Society, Inc.
 Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Directeur/Bestuurslid | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Corporate Officer/Principal | - |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Corporate Officer/Principal | - |
Opleiding van Arthur Levin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
26
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
miRagen Therapeutics, Inc. /Old/
miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops microRNA-based therapeutics for cardiovascular and muscle diseases | Health Technology |
Avidity Biosciences, Inc.
 Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Muhlenberg College
 Muhlenberg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Health Technology |
Oligonucleotide Therapeutics Society, Inc.
Oligonucleotide Therapeutics Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit forum for research and development of oligonucleotide therapeutics | Commercial Services |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Amylon Therapeutics BV
Amylon Therapeutics BV Pharmaceuticals: MajorHealth Technology Develops therapies for central nervous system | Health Technology |
